NCT03717844
- Conditions
- Abnormalities, Multiple, Amyloidosis, Blood Protein Disorders, +40 more
- Locations
-
- North Carolina Cancer Hospital Chapel Hill, North Carolina, United States
Clinical trial condition
Smoldering Multiple Myeloma
Explore clinical trials studying Smoldering Multiple Myeloma. Study availability and eligibility vary by location and protocol.
44 public trials
15 recruiting studies
Smoldering Multiple Myeloma trial results
NCT06365060
- Conditions
- Amyloidosis, Blood Protein Disorders, Hematologic Diseases, +15 more
- Locations
-
- University of Alabama Hospital Birmingham, Alabama, United States
- Cedars-Sinai Medical Center Los Angeles, California, United States
- University of California, San Francisco San Francisco, California, United States
- Cleveland Clinic Florida, Weston Hospital Weston, Florida, United States
NCT05841550
- Conditions
- Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +15 more
- Locations
-
- Oslo Myeloma Center Oslo, Norway
Recruiting
Whole Body MRI in Oncology
NCT06895291
- Conditions
- Advanced Breast Cancer, Advanced Prostate Cancer, Blood Protein Disorders, +20 more
- Locations
-
- IRCCS - Azienda Ospedaliero-Universitaria di Bologna - Policlinico di S. Orsola Bologna, BO, Italy
- IRCCS Istituto Romagnolo per lo Studio dei Tumori "Dino Amadori" - IRST S.r.l. Meldola, FC, Italy
- IRCCS Istituto Europeo di Oncologia S.r.l. Milan, MI, Italy
NCT05597345
- Conditions
- Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +15 more
- Locations
-
- University of Rochester Rochester, New York, United States
Enrolling by invitation
A Nationwide Phase 2 Trial of Patients With Smoldering and Active Multiple Myeloma (MM)
NCT03815279
- Conditions
- Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +15 more
- Locations
-
- Landspitali University Hospital Reykjavik, Iceland
Active, not recruiting
A Study of a Plant-Based Diet in People With Monoclonal Gammopathy of Undetermined Significance (MGUS) or Smoldering Multiple Myeloma (SMM)
NCT04920084
- Conditions
- Blood Protein Disorders, Hematologic Diseases, Hemic and Lymphatic Diseases, +8 more
- Locations
-
- Memorial Sloan Kettering Basking Ridge Basking Ridge, New Jersey, United States
- Memorial Sloan Kettering Monmouth Middletown, New Jersey, United States
- Memorial Sloan Kettering Bergen Montvale, New Jersey, United States
- Memorial Sloan Kettering Commack Commack, New York, United States
Active, not recruiting
Use of Elranatamab in Patients With High-risk Smoldering Multiple Myeloma
NCT06183489
- Conditions
- Blood Protein Disorders, Hematologic Diseases, Hemic and Lymphatic Diseases, +7 more
- Locations
-
- CHD Vendée La Roche-sur-Yon, France
- CHU Saint Eloi Département d'Hématologie Clinique Montpellier, France
- CHU Poitiers - Pôle régional de Cancérologie Poitiers, France
- CHRU Hôpital Bretonneau Tours, France
Active, not recruiting
Lenalidomide in Treating Patients With Multiple Myeloma Undergoing Autologous Stem Cell Transplant
NCT00114101
- Conditions
- Blood Protein Disorders, Cardiovascular Diseases, DS Stage I Multiple Myeloma, +19 more
- Locations
-
- Mayo Clinic in Arizona Scottsdale, Arizona, United States
- City of Hope Comprehensive Cancer Center Duarte, California, United States
- University of California Davis Comprehensive Cancer Center Sacramento, California, United States
- UC San Diego Medical Center - Hillcrest San Diego, California, United States
Active, not recruiting
Early Detection of Multiple Myeloma to Fight Cancer Disparities: A Screening and Patient Navigation Program
NCT05831358
- Conditions
- Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +16 more
- Locations
-
- Cleveland Clinic Taussig Cancer Institute, Case Comprehensive Cancer Center Cleveland, Ohio, United States